Sheldon Mullins

Sheldon Mullins currently serves as Vice President of Regulatory Affairs at Tempest Therapeutics since September 2024 and holds the position of Executive Director at Arrowhead Pharmaceuticals from October 2022. Since August 2011, Sheldon has been an instructor in the Master of Public Domain Management Program at San Jose State University and also teaches a regulatory affairs course at UCSC Extension in Silicon Valley since January 2009. Previously, Sheldon held senior regulatory affairs roles at various companies, including Senior Director at Ardelyx, Inc., Adverum Biotechnologies, Inc., Aquinox Pharmaceuticals, Inc., Onyx Pharmaceuticals, Achaogen, and PDL BioPharma between 2005 and 2022. Sheldon earned a Master of Science in Business Analysis from San Francisco State University and a Bachelor of Arts in Chemistry from Sonoma State University.